| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |